| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 1.06e-05 | 3 | 38 | 2 | GO:0035979 | |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 3.51e-05 | 5 | 38 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | histone modifying activity | 7.00e-05 | 229 | 38 | 5 | GO:0140993 | |
| GeneOntologyMolecularFunction | guanylyltransferase activity | 7.36e-05 | 7 | 38 | 2 | GO:0070568 | |
| GeneOntologyMolecularFunction | histone kinase activity | 1.29e-03 | 28 | 38 | 2 | GO:0035173 | |
| GeneOntologyBiologicalProcess | telomerase catalytic core complex assembly | 3.31e-06 | 2 | 38 | 2 | GO:1904868 | |
| GeneOntologyBiologicalProcess | positive regulation of telomerase catalytic core complex assembly | 3.31e-06 | 2 | 38 | 2 | GO:1904884 | |
| GeneOntologyBiologicalProcess | regulation of telomerase catalytic core complex assembly | 3.31e-06 | 2 | 38 | 2 | GO:1904882 | |
| GeneOntologyBiologicalProcess | growth hormone secretion | 8.67e-06 | 22 | 38 | 3 | GO:0030252 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization to telomere | 9.90e-06 | 3 | 38 | 2 | GO:0097694 | |
| GeneOntologyBiologicalProcess | establishment of protein-containing complex localization to telomere | 9.90e-06 | 3 | 38 | 2 | GO:0097695 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome organization | 4.41e-05 | 107 | 38 | 4 | GO:2001251 | |
| GeneOntologyBiologicalProcess | telomerase holoenzyme complex assembly | 4.93e-05 | 6 | 38 | 2 | GO:1905323 | |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | 1.11e-04 | 421 | 38 | 6 | GO:0010639 | |
| GeneOntologyBiologicalProcess | mitotic spindle assembly checkpoint signaling | 1.13e-04 | 51 | 38 | 3 | GO:0007094 | |
| GeneOntologyBiologicalProcess | spindle assembly checkpoint signaling | 1.13e-04 | 51 | 38 | 3 | GO:0071173 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 1.22e-04 | 266 | 38 | 5 | GO:0033044 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic sister chromatid separation | 1.27e-04 | 53 | 38 | 3 | GO:2000816 | |
| GeneOntologyBiologicalProcess | mitotic spindle checkpoint signaling | 1.27e-04 | 53 | 38 | 3 | GO:0071174 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic metaphase/anaphase transition | 1.27e-04 | 53 | 38 | 3 | GO:0045841 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic sister chromatid segregation | 1.27e-04 | 53 | 38 | 3 | GO:0033048 | |
| GeneOntologyBiologicalProcess | negative regulation of sister chromatid segregation | 1.27e-04 | 53 | 38 | 3 | GO:0033046 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome separation | 1.42e-04 | 55 | 38 | 3 | GO:1905819 | |
| GeneOntologyBiologicalProcess | negative regulation of metaphase/anaphase transition of cell cycle | 1.42e-04 | 55 | 38 | 3 | GO:1902100 | |
| GeneOntologyBiologicalProcess | spindle checkpoint signaling | 1.58e-04 | 57 | 38 | 3 | GO:0031577 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome segregation | 1.58e-04 | 57 | 38 | 3 | GO:0051985 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomerase | 1.84e-04 | 60 | 38 | 3 | GO:0032210 | |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid segregation | 1.84e-04 | 60 | 38 | 3 | GO:0033047 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic nuclear division | 2.22e-04 | 64 | 38 | 3 | GO:0045839 | |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid separation | 2.22e-04 | 64 | 38 | 3 | GO:0010965 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle checkpoint signaling | 2.25e-04 | 163 | 38 | 4 | GO:0007093 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid separation | 2.55e-04 | 67 | 38 | 3 | GO:0051306 | |
| GeneOntologyBiologicalProcess | cell cycle G2/M phase transition | 2.70e-04 | 171 | 38 | 4 | GO:0044839 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomere lengthening | 2.78e-04 | 69 | 38 | 3 | GO:1904356 | |
| GeneOntologyBiologicalProcess | negative regulation of nuclear division | 3.28e-04 | 73 | 38 | 3 | GO:0051784 | |
| GeneOntologyBiologicalProcess | histone mRNA catabolic process | 3.42e-04 | 15 | 38 | 2 | GO:0071044 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomerase | 3.84e-04 | 77 | 38 | 3 | GO:0007004 | |
| GeneOntologyBiologicalProcess | replicative senescence | 3.90e-04 | 16 | 38 | 2 | GO:0090399 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to heat | 3.90e-04 | 16 | 38 | 2 | GO:1900034 | |
| GeneOntologyBiologicalProcess | regulation of chromosome separation | 4.14e-04 | 79 | 38 | 3 | GO:1905818 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA damage response, signal transduction by p53 class mediator | 4.42e-04 | 17 | 38 | 2 | GO:0043517 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 4.79e-04 | 83 | 38 | 3 | GO:0006278 | |
| GeneOntologyBiologicalProcess | chromosome separation | 5.68e-04 | 88 | 38 | 3 | GO:0051304 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomere lengthening | 6.07e-04 | 90 | 38 | 3 | GO:0010833 | |
| GeneOntologyBiologicalProcess | negative regulation of triglyceride metabolic process | 6.15e-04 | 20 | 38 | 2 | GO:0090209 | |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | 6.65e-04 | 217 | 38 | 4 | GO:0000075 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 6.68e-04 | 93 | 38 | 3 | GO:0086003 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle phase transition | 6.88e-04 | 219 | 38 | 4 | GO:1901991 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 7.10e-04 | 95 | 38 | 3 | GO:0030071 | |
| GeneOntologyBiologicalProcess | RNA 3'-end processing | 7.78e-04 | 98 | 38 | 3 | GO:0031123 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 7.78e-04 | 98 | 38 | 3 | GO:1902099 | |
| GeneOntologyBiologicalProcess | clathrin coat assembly | 8.16e-04 | 23 | 38 | 2 | GO:0048268 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 8.25e-04 | 100 | 38 | 3 | GO:0007091 | |
| GeneOntologyBiologicalProcess | histone mRNA metabolic process | 8.89e-04 | 24 | 38 | 2 | GO:0008334 | |
| GeneOntologyBiologicalProcess | regulation of attachment of spindle microtubules to kinetochore | 8.89e-04 | 24 | 38 | 2 | GO:0051988 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 8.99e-04 | 103 | 38 | 3 | GO:0044784 | |
| GeneOntologyBiologicalProcess | hormone secretion | 9.86e-04 | 420 | 38 | 5 | GO:0046879 | |
| GeneOntologyBiologicalProcess | substrate adhesion-dependent cell spreading | 1.06e-03 | 109 | 38 | 3 | GO:0034446 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 1.12e-03 | 111 | 38 | 3 | GO:0033045 | |
| GeneOntologyBiologicalProcess | hormone transport | 1.12e-03 | 432 | 38 | 5 | GO:0009914 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance | 1.14e-03 | 112 | 38 | 3 | GO:0032204 | |
| GeneOntologyBiologicalProcess | regulation of G2/M transition of mitotic cell cycle | 1.27e-03 | 116 | 38 | 3 | GO:0010389 | |
| GeneOntologyBiologicalProcess | cellular response to gamma radiation | 1.30e-03 | 29 | 38 | 2 | GO:0071480 | |
| GeneOntologyBiologicalProcess | establishment of chromosome localization | 1.46e-03 | 122 | 38 | 3 | GO:0051303 | |
| GeneOntologyBiologicalProcess | triglyceride metabolic process | 1.64e-03 | 127 | 38 | 3 | GO:0006641 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.64e-03 | 127 | 38 | 3 | GO:0070252 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle | 1.75e-03 | 282 | 38 | 4 | GO:0045930 | |
| GeneOntologyBiologicalProcess | chromosome localization | 1.76e-03 | 130 | 38 | 3 | GO:0050000 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid catabolic process | 1.79e-03 | 34 | 38 | 2 | GO:0050995 | |
| GeneOntologyBiologicalProcess | positive regulation of signal transduction by p53 class mediator | 1.79e-03 | 34 | 38 | 2 | GO:1901798 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G2/M phase transition | 1.80e-03 | 131 | 38 | 3 | GO:1902749 | |
| GeneOntologyBiologicalProcess | regulation of mitotic nuclear division | 1.92e-03 | 134 | 38 | 3 | GO:0007088 | |
| GeneOntologyBiologicalProcess | post-embryonic development | 1.96e-03 | 135 | 38 | 3 | GO:0009791 | |
| GeneOntologyBiologicalProcess | positive regulation of telomere maintenance via telomerase | 2.00e-03 | 36 | 38 | 2 | GO:0032212 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 2.00e-03 | 36 | 38 | 2 | GO:0086010 | |
| GeneOntologyBiologicalProcess | regulation of DNA biosynthetic process | 2.08e-03 | 138 | 38 | 3 | GO:2000278 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 2.13e-03 | 139 | 38 | 3 | GO:0051983 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle phase transition | 2.30e-03 | 509 | 38 | 5 | GO:0044772 | |
| GeneOntologyBiologicalProcess | positive regulation of telomere maintenance via telomere lengthening | 2.35e-03 | 39 | 38 | 2 | GO:1904358 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | 2.42e-03 | 515 | 38 | 5 | GO:0022613 | |
| GeneOntologyBiologicalProcess | regulation of DNA damage response, signal transduction by p53 class mediator | 2.47e-03 | 40 | 38 | 2 | GO:0043516 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle phase transition | 2.50e-03 | 311 | 38 | 4 | GO:1901988 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance | 2.72e-03 | 42 | 38 | 2 | GO:0032205 | |
| GeneOntologyBiologicalProcess | G2/M transition of mitotic cell cycle | 2.74e-03 | 152 | 38 | 3 | GO:0000086 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.79e-03 | 153 | 38 | 3 | GO:0030048 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell contraction | 2.85e-03 | 43 | 38 | 2 | GO:0086004 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA metabolic process | 2.90e-03 | 155 | 38 | 3 | GO:0051053 | |
| GeneOntologyBiologicalProcess | acylglycerol metabolic process | 2.95e-03 | 156 | 38 | 3 | GO:0006639 | |
| GeneOntologyBiologicalProcess | secretion by cell | 2.95e-03 | 1064 | 38 | 7 | GO:0032940 | |
| GeneOntologyBiologicalProcess | positive regulation of peptide hormone secretion | 3.00e-03 | 157 | 38 | 3 | GO:0090277 | |
| GeneOntologyBiologicalProcess | neutral lipid metabolic process | 3.06e-03 | 158 | 38 | 3 | GO:0006638 | |
| GeneOntologyBiologicalProcess | positive regulation of peptide secretion | 3.22e-03 | 161 | 38 | 3 | GO:0002793 | |
| GeneOntologyBiologicalProcess | peptide hormone secretion | 3.23e-03 | 334 | 38 | 4 | GO:0030072 | |
| GeneOntologyBiologicalProcess | mRNA 3'-end processing | 3.25e-03 | 46 | 38 | 2 | GO:0031124 | |
| Domain | Clathrin_b-adaptin_app_Ig-like | 3.61e-06 | 2 | 36 | 2 | IPR013037 | |
| Domain | - | 3.61e-06 | 2 | 36 | 2 | 2.60.40.1150 | |
| Domain | AP_complex_bsu_1_2_4 | 1.08e-05 | 3 | 36 | 2 | IPR016342 | |
| Domain | B2-adapt-app_C | 1.08e-05 | 3 | 36 | 2 | PF09066 | |
| Domain | B-adaptin_app_sub_C | 2.16e-05 | 4 | 36 | 2 | IPR015151 | |
| Domain | B2-adapt-app_C | 2.16e-05 | 4 | 36 | 2 | SM01020 | |
| Domain | FATC | 3.60e-05 | 5 | 36 | 2 | PF02260 | |
| Domain | AP_beta | 3.60e-05 | 5 | 36 | 2 | IPR026739 | |
| Domain | FAT | 5.39e-05 | 6 | 36 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 5.39e-05 | 6 | 36 | 2 | IPR003151 | |
| Domain | FATC_dom | 5.39e-05 | 6 | 36 | 2 | IPR003152 | |
| Domain | PIK_FAT | 5.39e-05 | 6 | 36 | 2 | IPR014009 | |
| Domain | FAT | 5.39e-05 | 6 | 36 | 2 | PS51189 | |
| Domain | FATC | 5.39e-05 | 6 | 36 | 2 | PS51190 | |
| Domain | Beta2_adaptin/TBP_C_dom | 5.39e-05 | 6 | 36 | 2 | IPR012295 | |
| Domain | FATC | 5.39e-05 | 6 | 36 | 2 | SM01343 | |
| Domain | - | 5.39e-05 | 6 | 36 | 2 | 3.30.310.10 | |
| Domain | Coatomer/calthrin_app_sub_C | 1.00e-04 | 8 | 36 | 2 | IPR009028 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 1.29e-04 | 9 | 36 | 2 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 1.29e-04 | 9 | 36 | 2 | PF02883 | |
| Domain | Alpha_adaptinC2 | 1.29e-04 | 9 | 36 | 2 | SM00809 | |
| Domain | ARM-like | 1.59e-04 | 270 | 36 | 5 | IPR011989 | |
| Domain | Coatomer/clathrin_app_Ig-like | 2.36e-04 | 12 | 36 | 2 | IPR013041 | |
| Domain | Clathrin/coatomer_adapt-like_N | 3.73e-04 | 15 | 36 | 2 | IPR002553 | |
| Domain | Adaptin_N | 3.73e-04 | 15 | 36 | 2 | PF01602 | |
| Domain | PI3/4_kinase_CS | 3.73e-04 | 15 | 36 | 2 | IPR018936 | |
| Domain | PI3Kc | 4.26e-04 | 16 | 36 | 2 | SM00146 | |
| Domain | - | 4.26e-04 | 16 | 36 | 2 | 1.10.1070.11 | |
| Domain | ARM-type_fold | 4.54e-04 | 339 | 36 | 5 | IPR016024 | |
| Domain | Cyclin_C-dom | 4.82e-04 | 17 | 36 | 2 | IPR004367 | |
| Domain | Cyclin_C | 4.82e-04 | 17 | 36 | 2 | PF02984 | |
| Domain | Cyclin_C | 4.82e-04 | 17 | 36 | 2 | SM01332 | |
| Domain | PI3_4_KINASE_1 | 5.42e-04 | 18 | 36 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 5.42e-04 | 18 | 36 | 2 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 5.42e-04 | 18 | 36 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 5.42e-04 | 18 | 36 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 5.42e-04 | 18 | 36 | 2 | PS50290 | |
| Domain | CYCLINS | 1.32e-03 | 28 | 36 | 2 | PS00292 | |
| Domain | Cyclin_N | 1.84e-03 | 33 | 36 | 2 | IPR006671 | |
| Domain | Cyclin_N | 1.84e-03 | 33 | 36 | 2 | PF00134 | |
| Domain | CYCLIN | 2.43e-03 | 38 | 36 | 2 | SM00385 | |
| Domain | - | 2.69e-03 | 40 | 36 | 2 | 1.10.472.10 | |
| Domain | ARM | 2.69e-03 | 40 | 36 | 2 | SM00185 | |
| Domain | Cyclin-like | 3.10e-03 | 43 | 36 | 2 | IPR013763 | |
| Domain | Armadillo | 3.70e-03 | 47 | 36 | 2 | IPR000225 | |
| Domain | Channel_four-helix_dom | 5.39e-03 | 57 | 36 | 2 | IPR027359 | |
| Domain | - | 5.39e-03 | 57 | 36 | 2 | 1.20.120.350 | |
| Domain | EGF_extracell | 5.96e-03 | 60 | 36 | 2 | IPR013111 | |
| Domain | EGF_2 | 5.96e-03 | 60 | 36 | 2 | PF07974 | |
| Domain | Zinc_finger_PHD-type_CS | 6.96e-03 | 65 | 36 | 2 | IPR019786 | |
| Domain | - | 8.86e-03 | 222 | 36 | 3 | 1.25.10.10 | |
| Domain | PHD | 9.18e-03 | 75 | 36 | 2 | PF00628 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ATR_P21_CELL_CYCLE_G2_M | 2.39e-09 | 9 | 31 | 4 | M47586 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CDC25_CELL_CYCLE_G2_M | 3.98e-09 | 10 | 31 | 4 | M47572 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WEE1_CELL_CYCLE_G2_M | 3.35e-07 | 7 | 31 | 3 | M47574 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_CDC25_CELL_CYCLE_G2M | 1.57e-06 | 11 | 31 | 3 | M47573 | |
| Pathway | REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION | 3.45e-06 | 14 | 31 | 3 | M26983 | |
| Pathway | WP_P53_SIGNALING | 1.18e-05 | 65 | 31 | 4 | MM15852 | |
| Pathway | KEGG_P53_SIGNALING_PATHWAY | 1.41e-05 | 68 | 31 | 4 | M6370 | |
| Pathway | WP_DNA_DAMAGE_RESPONSE | 1.50e-05 | 69 | 31 | 4 | M39339 | |
| Pathway | BIOCARTA_G2_PATHWAY | 1.89e-05 | 24 | 31 | 3 | M8560 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_WEE1_CELL_CYCLE_G2M | 4.66e-05 | 5 | 31 | 2 | M49022 | |
| Pathway | REACTOME_ACTIVATION_OF_NIMA_KINASES_NEK9_NEK6_NEK7 | 4.66e-05 | 5 | 31 | 2 | MM14918 | |
| Pathway | REACTOME_G2_M_DNA_REPLICATION_CHECKPOINT | 4.66e-05 | 5 | 31 | 2 | M27669 | |
| Pathway | REACTOME_G2_M_DNA_REPLICATION_CHECKPOINT | 4.66e-05 | 5 | 31 | 2 | MM15382 | |
| Pathway | WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE | 5.98e-05 | 98 | 31 | 4 | M39524 | |
| Pathway | REACTOME_ACTIVATION_OF_NIMA_KINASES_NEK9_NEK6_NEK7 | 9.76e-05 | 7 | 31 | 2 | M27213 | |
| Pathway | BIOCARTA_PLK3_PATHWAY | 1.30e-04 | 8 | 31 | 2 | M22021 | |
| Pathway | WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME | 1.30e-04 | 8 | 31 | 2 | M42528 | |
| Pathway | WP_CELL_CYCLE | 1.32e-04 | 120 | 31 | 4 | M39650 | |
| Pathway | KEGG_CELL_CYCLE | 1.54e-04 | 125 | 31 | 4 | M7963 | |
| Pathway | REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES | 2.54e-04 | 11 | 31 | 2 | M27182 | |
| Pathway | PID_P53_REGULATION_PATHWAY | 2.88e-04 | 59 | 31 | 3 | M261 | |
| Pathway | BIOCARTA_EFP_PATHWAY | 3.60e-04 | 13 | 31 | 2 | MM1537 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 3.96e-04 | 291 | 31 | 5 | M16647 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 4.66e-04 | 167 | 31 | 4 | M19381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P300_P21_CELL_CYCLE_G1_S | 4.83e-04 | 15 | 31 | 2 | M47524 | |
| Pathway | REACTOME_POLO_LIKE_KINASE_MEDIATED_EVENTS | 5.51e-04 | 16 | 31 | 2 | M26971 | |
| Pathway | BIOCARTA_EFP_PATHWAY | 5.51e-04 | 16 | 31 | 2 | M22011 | |
| Pathway | REACTOME_INITIATION_OF_NUCLEAR_ENVELOPE_NE_REFORMATION | 6.24e-04 | 17 | 31 | 2 | MM14920 | |
| Pathway | REACTOME_INITIATION_OF_NUCLEAR_ENVELOPE_NE_REFORMATION | 7.82e-04 | 19 | 31 | 2 | M29617 | |
| Pathway | REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS | 9.58e-04 | 21 | 31 | 2 | M12347 | |
| Pathway | BIOCARTA_ATRBRCA_PATHWAY | 1.05e-03 | 22 | 31 | 2 | M9703 | |
| Pathway | BIOCARTA_G2_PATHWAY | 1.05e-03 | 22 | 31 | 2 | MM1365 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 1.13e-03 | 94 | 31 | 3 | M1080 | |
| Pathway | REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | 1.36e-03 | 25 | 31 | 2 | MM15379 | |
| Pathway | REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | 1.36e-03 | 25 | 31 | 2 | M808 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY | 1.47e-03 | 26 | 31 | 2 | M47719 | |
| Pathway | REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS | 1.71e-03 | 28 | 31 | 2 | M11362 | |
| Pathway | BIOCARTA_G1_PATHWAY | 1.71e-03 | 28 | 31 | 2 | M648 | |
| Pathway | PID_BARD1_PATHWAY | 1.83e-03 | 29 | 31 | 2 | M258 | |
| Pathway | PID_CDC42_REG_PATHWAY | 1.96e-03 | 30 | 31 | 2 | M83 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 1.96e-03 | 114 | 31 | 3 | MM15361 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 2.23e-03 | 32 | 31 | 2 | M27455 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 2.37e-03 | 33 | 31 | 2 | M188 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 2.67e-03 | 127 | 31 | 3 | M27181 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 2.79e-03 | 129 | 31 | 3 | MM14894 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 2.79e-03 | 271 | 31 | 4 | MM15388 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 2.81e-03 | 36 | 31 | 2 | M27245 | |
| Pathway | REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA | 2.97e-03 | 37 | 31 | 2 | M27568 | |
| Pathway | WP_ATM_SIGNALING | 3.47e-03 | 40 | 31 | 2 | M39433 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 3.47e-03 | 40 | 31 | 2 | MM14945 | |
| Pathway | PID_FOXM1_PATHWAY | 3.47e-03 | 40 | 31 | 2 | M176 | |
| Pathway | REACTOME_CELL_CYCLE | 3.57e-03 | 694 | 31 | 6 | M543 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 3.66e-03 | 142 | 31 | 3 | M27660 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 3.73e-03 | 143 | 31 | 3 | MM15383 | |
| Pathway | REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE | 4.00e-03 | 43 | 31 | 2 | M27588 | |
| Pathway | PID_PLK1_PATHWAY | 4.56e-03 | 46 | 31 | 2 | M129 | |
| Pathway | PID_DELTA_NP63_PATHWAY | 4.76e-03 | 47 | 31 | 2 | M236 | |
| Pathway | WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE | 4.76e-03 | 47 | 31 | 2 | M39518 | |
| Pathway | PID_FANCONI_PATHWAY | 4.76e-03 | 47 | 31 | 2 | M1 | |
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 9707615 | ||
| Pubmed | 1.56e-07 | 10 | 39 | 3 | 17478428 | ||
| Pubmed | Alternative Functions of Cell Cycle-Related and DNA Repair Proteins in Post-mitotic Neurons. | 6.73e-07 | 61 | 39 | 4 | 34746147 | |
| Pubmed | Expression of murine cyclin B1 mRNAs and genetic mapping of related genomic sequences. | 1.05e-06 | 18 | 39 | 3 | 1387105 | |
| Pubmed | Single-stranded DNA orchestrates an ATM-to-ATR switch at DNA breaks. | 1.23e-06 | 2 | 39 | 2 | 19285939 | |
| Pubmed | DNA damage-sensing kinases mediate the mouse 2-cell embryo's response to genotoxic stress. | 1.23e-06 | 2 | 39 | 2 | 21593482 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 25232030 | ||
| Pubmed | Expression variations of DNA damage response genes ATM and ATR in blood cancer patients. | 1.23e-06 | 2 | 39 | 2 | 37338595 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 28851706 | ||
| Pubmed | ATM acts downstream of ATR in the DNA damage response signaling of bystander cells. | 1.23e-06 | 2 | 39 | 2 | 18757420 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 11927575 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 28820634 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 29279380 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 12526805 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 8375336 | ||
| Pubmed | The kinetics of G2 and M transitions regulated by B cyclins. | 1.23e-06 | 2 | 39 | 2 | 24324638 | |
| Pubmed | Novel insights into the mechanism of cell cycle kinases Mec1(ATR) and Tel1(ATM). | 1.23e-06 | 2 | 39 | 2 | 34151669 | |
| Pubmed | Inhibition of Atm and/or Atr disrupts gene silencing on the inactive X chromosome. | 1.23e-06 | 2 | 39 | 2 | 16213462 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 27442013 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 24726882 | ||
| Pubmed | 5'-UTR and ORF elements, as well as the 3'-UTR regulate the translation of Cyclin. | 1.23e-06 | 2 | 39 | 2 | 32439164 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 24238855 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 16474843 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 29074977 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 8843195 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 26061708 | ||
| Pubmed | Viral DNA replication-dependent DNA damage response activation during BK polyomavirus infection. | 1.23e-06 | 2 | 39 | 2 | 25694603 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 26124337 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 25812484 | ||
| Pubmed | Roles of ATM and ATR-mediated DNA damage responses during lytic BK polyomavirus infection. | 1.23e-06 | 2 | 39 | 2 | 22952448 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 20103595 | ||
| Pubmed | ATM regulates ATR chromatin loading in response to DNA double-strand breaks. | 1.23e-06 | 2 | 39 | 2 | 16461339 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 29074707 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 23297361 | ||
| Pubmed | Interplay between ATM and ATR in the regulation of common fragile site stability. | 1.23e-06 | 2 | 39 | 2 | 17934520 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 23272087 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 25483091 | ||
| Pubmed | ATM and ATR activities maintain replication fork integrity during SV40 chromatin replication. | 1.23e-06 | 2 | 39 | 2 | 23592994 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 27129217 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 19527713 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 20368801 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 30746633 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 33640756 | ||
| Pubmed | A role for ATR in the DNA damage-induced phosphorylation of p53. | 1.23e-06 | 2 | 39 | 2 | 9925639 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 21908846 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 26567218 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 29263259 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 30097513 | ||
| Pubmed | An S/T-Q cluster domain census unveils new putative targets under Tel1/Mec1 control. | 1.23e-06 | 2 | 39 | 2 | 23176708 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 26743489 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 15533933 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 17124492 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 33742106 | ||
| Pubmed | Roles of ATM and ATR in DNA double strand breaks and replication stress. | 1.23e-06 | 2 | 39 | 2 | 33887296 | |
| Pubmed | ATR disruption leads to chromosomal fragmentation and early embryonic lethality. | 1.23e-06 | 2 | 39 | 2 | 10691732 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 12519769 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 17533373 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 31114877 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 38241547 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 35011623 | ||
| Pubmed | Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null mice die in utero. | 1.23e-06 | 2 | 39 | 2 | 9539739 | |
| Pubmed | The association of ATR protein with mouse meiotic chromosome cores. | 1.23e-06 | 2 | 39 | 2 | 10382071 | |
| Pubmed | Overexpression of B-type cyclins alters chromosomal segregation. | 1.23e-06 | 2 | 39 | 2 | 11960377 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 26517239 | ||
| Pubmed | Substrate specificities and identification of putative substrates of ATM kinase family members. | 2.95e-06 | 25 | 39 | 3 | 10608806 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 26563132 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 34301763 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 25846551 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 1717476 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 33397932 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 23438602 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 28592488 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 18344416 | ||
| Pubmed | Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. | 3.67e-06 | 3 | 39 | 2 | 9766667 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 16741947 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 27625305 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 18451257 | ||
| Pubmed | A subset of ATM- and ATR-dependent phosphorylation events requires the BRCA1 protein. | 3.67e-06 | 3 | 39 | 2 | 12773400 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 21844338 | ||
| Pubmed | Key mediators of somatic ATR signaling localize to unpaired chromosomes in spermatocytes. | 3.67e-06 | 3 | 39 | 2 | 26209650 | |
| Pubmed | Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance. | 3.67e-06 | 3 | 39 | 2 | 16943440 | |
| Pubmed | DNA Damage Signaling Is Required for Replication of Human Bocavirus 1 DNA in Dividing HEK293 Cells. | 3.67e-06 | 3 | 39 | 2 | 27733644 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 38970714 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 17409144 | ||
| Pubmed | Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. | 3.67e-06 | 3 | 39 | 2 | 11114888 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 32863381 | ||
| Pubmed | Distinct roles of ATR and DNA-PKcs in triggering DNA damage responses in ATM-deficient cells. | 3.67e-06 | 3 | 39 | 2 | 19444312 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 15735814 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 31601897 | ||
| Pubmed | ATM/ATR checkpoint activation downregulates CDC25C to prevent mitotic entry with uncapped telomeres. | 3.67e-06 | 3 | 39 | 2 | 22842784 | |
| Pubmed | Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. | 3.67e-06 | 3 | 39 | 2 | 9733515 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 27472395 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 7737117 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 16122425 | ||
| Pubmed | Proapoptotic BID is an ATM effector in the DNA-damage response. | 3.67e-06 | 3 | 39 | 2 | 16122426 | |
| Pubmed | ATM Kinase Is Required for Telomere Elongation in Mouse and Human Cells. | 3.67e-06 | 3 | 39 | 2 | 26586427 | |
| Pubmed | The roles of cyclin A2, B1, and B2 in early and late mitotic events. | 3.67e-06 | 3 | 39 | 2 | 20660152 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 31164689 | ||
| Pubmed | Rapid activation of ATR by ionizing radiation requires ATM and Mre11. | 3.67e-06 | 3 | 39 | 2 | 16431910 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 11278964 | ||
| GeneFamily | Cyclins | 5.24e-04 | 28 | 22 | 2 | 473 | |
| GeneFamily | PHD finger proteins | 5.31e-03 | 90 | 22 | 2 | 88 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.57e-02 | 206 | 22 | 2 | 682 | |
| Coexpression | GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_UP | 1.01e-05 | 200 | 38 | 5 | M8075 | |
| Coexpression | ZERBINI_RESPONSE_TO_SULINDAC_DN | 3.06e-05 | 6 | 38 | 2 | M17956 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | 3.16e-05 | 426 | 38 | 6 | M9516 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.42e-07 | 195 | 39 | 5 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-05 | 164 | 39 | 4 | e5258efd6765acfc394708f697ec76acaef09079 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-05 | 171 | 39 | 4 | 845f312f8cbe29d820da25f0e6d75deb382bbfd8 | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.87e-05 | 181 | 39 | 4 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.87e-05 | 181 | 39 | 4 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 183 | 39 | 4 | 42dc31d587fbb9724b2f0be5ee8ed77233f67b86 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.95e-05 | 183 | 39 | 4 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.03e-05 | 185 | 39 | 4 | 57c1eb50a4456d20953e48d5dc3b0ea3d0d81b6d | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.78e-04 | 125 | 39 | 3 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.00e-04 | 130 | 39 | 3 | a3e12984fb61311e49cc76c59f74f4dffc48faa1 | |
| ToppCell | Lymphoid-T_cells_(cycle)|World / shred on cell class and cell subclass (v4) | 2.64e-04 | 143 | 39 | 3 | 2fbcca395971a8452f68481282a74cec4005d1e2 | |
| ToppCell | LA-15._Ventricular_Cardiomyocyte_III|LA / Chamber and Cluster_Paper | 2.86e-04 | 147 | 39 | 3 | 8970eb6b82589f39439c61a57d999661ec8342de | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-04 | 149 | 39 | 3 | 48fca6ae33d7722c024b43ce04f4dbce7b6b424b | |
| ToppCell | droplet-Lung-nan-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-04 | 151 | 39 | 3 | c743dc8758416a4f562d60c8fd2df7e659ab6951 | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-macrophage-B|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.16e-04 | 152 | 39 | 3 | 5ce8920aedd39a4daf7082153b5e213707c14227 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.22e-04 | 153 | 39 | 3 | c4dcdcaa672929c1da870e9fb8ada1bb030ad12f | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.22e-04 | 153 | 39 | 3 | d7635f3d4831c02a94f53afc674847d5b51453be | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.22e-04 | 153 | 39 | 3 | e50d20f9e553b8c3e10e187770d8abe1a43d109e | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.22e-04 | 153 | 39 | 3 | 54a941950bbb848077c7bd5726da9e4b3244bd38 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.22e-04 | 153 | 39 | 3 | 69a8550418ba0fc908a84b3b85761abb6e8ca4c0 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 154 | 39 | 3 | a5289000597068ee8d559f89bce7bce31f35dd57 | |
| ToppCell | PND07-28-samps|World / Age Group, Lineage, Cell class and subclass | 3.47e-04 | 157 | 39 | 3 | a2005768a6d268879e3fd6dbd8cf674dc98be587 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 3.60e-04 | 159 | 39 | 3 | f34f2729a3872fbb2939e76ad35d7e25f71b8f57 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal-Unfolded_protein_responsible_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 3.60e-04 | 159 | 39 | 3 | 929ed98f6c2ad14e8d5af5c6f11a5a3d4b388cf7 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.67e-04 | 160 | 39 | 3 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage-macrophage-B|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.67e-04 | 160 | 39 | 3 | 694bf1f1952bd8ab444819f533da24fa2b73f701 | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-CD163+_Macrophage|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.67e-04 | 160 | 39 | 3 | 4480a7d6bd48d06b4e5196faac868f31ab7ed3ad | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.74e-04 | 161 | 39 | 3 | 0dd1401b4c990d49fccb702a9f9867590a58e203 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-DC3|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.74e-04 | 161 | 39 | 3 | 39030380e04f57f8e7de231577ec3177e1b6490d | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.74e-04 | 161 | 39 | 3 | b6a31c033edc74f23a20aab1f18e80cc83ffee4c | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 3.74e-04 | 161 | 39 | 3 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.74e-04 | 161 | 39 | 3 | efb811dda4d73107983a5f68302bdcf4f408d5b4 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.74e-04 | 161 | 39 | 3 | 28d5dbd20c9f8e0069f172d552997a044790e1a7 | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.81e-04 | 162 | 39 | 3 | 7c73fe8388af370461e04097cf145cbc9847285b | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.88e-04 | 163 | 39 | 3 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.95e-04 | 164 | 39 | 3 | ad508f53009efdd1dae7abcdb5431387f3f7e7b2 | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.95e-04 | 164 | 39 | 3 | 49733a9d3d95f05056b5b01916060ff20a8de3cf | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.02e-04 | 165 | 39 | 3 | 26c750f10f6401752e2e63d91dc844c81b29d735 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.02e-04 | 165 | 39 | 3 | a5c3af634d2698f9a01cf074791756b7669f9fff | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-04 | 165 | 39 | 3 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.16e-04 | 167 | 39 | 3 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-04 | 167 | 39 | 3 | 1bd27ffe381d26731b6d4cc5f29b27f1bac4473b | |
| ToppCell | PND07-28-samps-Myeloid|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.23e-04 | 168 | 39 | 3 | 87512f9e5e95333e7ffc6efa1e93bab2ba9154c6 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-04 | 169 | 39 | 3 | 1558606be0a8bcd4fd0ce609701a1411e4ca2f9f | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-04 | 169 | 39 | 3 | 1b2354de1ce4080118d9f01e7c5fd6079e705125 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.38e-04 | 170 | 39 | 3 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.38e-04 | 170 | 39 | 3 | 6b91d4cbe0697b65bfb2e099e7a9b39ea2fba3a9 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.38e-04 | 170 | 39 | 3 | da4dde7d0491ccc298cec7474a6a76ff3db36a4c | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.38e-04 | 170 | 39 | 3 | b04e2f84024baaae9b4ff19bdac8c69afdb92a76 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.46e-04 | 171 | 39 | 3 | 4ede6e916e593f208f2f8ccf82ef2335e061fc86 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 4.46e-04 | 171 | 39 | 3 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC-DC-tDC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.46e-04 | 171 | 39 | 3 | b327fb7813a3cdae06c8a4f8a0c256e9a20132f6 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.53e-04 | 172 | 39 | 3 | 282017db72d0537ac82aecc69393ccde9590be60 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 172 | 39 | 3 | 35c20de4db47dbf31c857d23c7a25cd7f95c085c | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.53e-04 | 172 | 39 | 3 | 4bdcf1ae2a1cfba0272c54072e37fb7958904321 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue | 4.61e-04 | 173 | 39 | 3 | 783b8fa08b9d8f597f251793eae164151662f1f9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.61e-04 | 173 | 39 | 3 | 61907116a1460bc157ba73b5edd108db7dd5de4b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.69e-04 | 174 | 39 | 3 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.69e-04 | 174 | 39 | 3 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.77e-04 | 175 | 39 | 3 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.77e-04 | 175 | 39 | 3 | 0b1aaa028ba844d4bcb4509fdab8bee648373935 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.77e-04 | 175 | 39 | 3 | ae7e0448ffd11b8908d0f6d99ff737faf5eca4bf | |
| ToppCell | Club-club-15|World / Class top | 4.77e-04 | 175 | 39 | 3 | ca9d012f520f697c7450ec6958a015e20538a6a8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-04 | 175 | 39 | 3 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.77e-04 | 175 | 39 | 3 | 9de288c338cee67be0e9b836c87799bbc1db1c38 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.85e-04 | 176 | 39 | 3 | 581045e61cdcdfa85701343d1a7c0a72a36606a7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.85e-04 | 176 | 39 | 3 | d09e28606e2a6ed1f660898316765ca215085c18 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.85e-04 | 176 | 39 | 3 | b794275fdd757b8fa2108e3c867f23da2649146d | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.85e-04 | 176 | 39 | 3 | b0b87eebcf5c994386b39ca607e17f10e9d9de74 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-04 | 177 | 39 | 3 | e9d7682517fb30fd2ad535d59779d718a7024c13 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.93e-04 | 177 | 39 | 3 | 67cc3a6461db5e0678f96b18224aeb83ad34b0f4 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-04 | 177 | 39 | 3 | 8a0f0fbb06cdacb99a3fdba0da3e0494b891db4f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.93e-04 | 177 | 39 | 3 | 1cb78133ac09ea3a3f5b5de07151033998406512 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.01e-04 | 178 | 39 | 3 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.01e-04 | 178 | 39 | 3 | c7e890cd02206c516cf1d7692ea7abc8ce746482 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.09e-04 | 179 | 39 | 3 | c7afbd10072d36a35cd20ae73670d76b9cefd22d | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.09e-04 | 179 | 39 | 3 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.09e-04 | 179 | 39 | 3 | 3b0f8781232e1d42b6f8913bc989a14b3f978e79 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.18e-04 | 180 | 39 | 3 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.18e-04 | 180 | 39 | 3 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.18e-04 | 180 | 39 | 3 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.26e-04 | 181 | 39 | 3 | 153709b4dd3d81e09f251fa8765b58bed1932fda | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.26e-04 | 181 | 39 | 3 | 0c5bc1660b8fc1e905ab4230202862de5be46ebd | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.26e-04 | 181 | 39 | 3 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | Healthy_Control-Lymphoid-T-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.26e-04 | 181 | 39 | 3 | ac1ee313910c05b1b3cb497bae14565464919c21 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.26e-04 | 181 | 39 | 3 | 74311aac2fe27dc02a9be3bc20e0c7ef1c239049 | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.26e-04 | 181 | 39 | 3 | f83565f09dd971c5cad2704a4a86bca0accd955e | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.26e-04 | 181 | 39 | 3 | cf13bf7a531a2d40f8d778629cf2431b684f65f3 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating-Lymphatic_EC_proliferating_L.2.5.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.35e-04 | 182 | 39 | 3 | f703963b5d1e8c1f95d78807521048553b0792d8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.35e-04 | 182 | 39 | 3 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.35e-04 | 182 | 39 | 3 | 21dcab170ffeef89faa9fee5008568cb6e15c694 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.35e-04 | 182 | 39 | 3 | 94d061b7b5ebbfc564c644bc8b2d52341927145d | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 5.35e-04 | 182 | 39 | 3 | 84018a84e1aa52fa52ccfc26db9cd1fb6d535b31 | |
| ToppCell | severe-multiplets|World / disease stage, cell group and cell class | 5.35e-04 | 182 | 39 | 3 | 5e30ec7120a988d9ee3000513e1209618f28f5f9 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.35e-04 | 182 | 39 | 3 | b1e66ccd5f33b4801f1cafddf97f5fc0c6dba8d1 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.35e-04 | 182 | 39 | 3 | ebd177ad5eac51bf2db0657596618bdf1e5d46e1 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 5.43e-04 | 183 | 39 | 3 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.43e-04 | 183 | 39 | 3 | 6e6128c5be5e0a2db6d84eecbf4dddd02d0216f8 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.43e-04 | 183 | 39 | 3 | 29b62dd542bc3f8df843998f577724f3818d4271 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.43e-04 | 183 | 39 | 3 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.28e-04 | 50 | 26 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_29_NPC_OPC | |
| Drug | 1,1,1-trichloroethane | 6.76e-06 | 156 | 39 | 5 | CID000006278 | |
| Drug | Flavanones | 9.17e-06 | 24 | 39 | 3 | ctd:D044950 | |
| Drug | 1fl3 | 1.71e-05 | 4 | 39 | 2 | CID000445650 | |
| Drug | Neostigmine bromide [114-80-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.99e-05 | 195 | 39 | 5 | 3294_UP | |
| Drug | Chlorpyrifos | 2.74e-05 | 960 | 39 | 9 | ctd:D004390 | |
| Drug | aminopyrazine | 2.85e-05 | 5 | 39 | 2 | CID000078747 | |
| Drug | Pyrazolopyridazine 1a | 2.85e-05 | 5 | 39 | 2 | CID006263849 | |
| Drug | alsterpaullone | 2.93e-05 | 35 | 39 | 3 | CID005005498 | |
| Drug | 4,4'-thiodipyridine | 4.27e-05 | 6 | 39 | 2 | CID000604650 | |
| Drug | KU55933 | 7.62e-05 | 48 | 39 | 3 | CID005278396 | |
| Drug | 3-(N-morpholino)propanesulfonic acid | 7.62e-05 | 48 | 39 | 3 | CID000070807 | |
| Drug | Mirex | 7.62e-05 | 48 | 39 | 3 | ctd:D008917 | |
| Drug | hellebrigenin | 7.95e-05 | 8 | 39 | 2 | ctd:C001330 | |
| Disease | ataxia telangiectasia (implicated_via_orthology) | 1.70e-06 | 2 | 39 | 2 | DOID:12704 (implicated_via_orthology) | |
| Disease | Benign neoplasm of stomach | 2.29e-04 | 17 | 39 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.29e-04 | 17 | 39 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 2.29e-04 | 17 | 39 | 2 | C0154060 | |
| Disease | Stomach Carcinoma | 3.52e-04 | 21 | 39 | 2 | C0699791 | |
| Disease | Immunologic Deficiency Syndromes | 4.23e-04 | 23 | 39 | 2 | C0021051 | |
| Disease | melanoma | 6.21e-04 | 126 | 39 | 3 | EFO_0000756 | |
| Disease | breast cancer (is_implicated_in) | 1.03e-03 | 150 | 39 | 3 | DOID:1612 (is_implicated_in) | |
| Disease | myositis | 1.22e-03 | 39 | 39 | 2 | EFO_0000783 | |
| Disease | Inherited neuropathies | 1.29e-03 | 40 | 39 | 2 | C0598589 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 1.49e-03 | 43 | 39 | 2 | DOID:9261 (is_marker_for) | |
| Disease | optic disc area measurement | 1.63e-03 | 45 | 39 | 2 | EFO_0006937 | |
| Disease | Squamous cell carcinoma of the head and neck | 2.16e-03 | 52 | 39 | 2 | C1168401 | |
| Disease | platelet component distribution width | 3.03e-03 | 755 | 39 | 5 | EFO_0007984 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LYLMNYAKSQPDMAI | 71 | P63010 | |
| EQELPFYFLQKLLMM | 896 | Q7Z2Y8 | |
| YRQLLLFYSKNPAMM | 286 | Q96M93 | |
| LNLMPQMKTLYLTYC | 351 | Q14155 | |
| LYLMNYAKSQPDMAI | 71 | Q10567 | |
| MEYPAIMLKELNSYS | 611 | Q9P1Z9 | |
| VSAALTLMMPYYLLD | 306 | P52569 | |
| MSSMNPEYDYLFKLL | 1 | P62820 | |
| MKDSLLPDDLYMSFL | 301 | Q6ZRI8 | |
| QKNMLDGYRPSMLYI | 346 | Q8NDF8 | |
| MAMLYPELYKDLTKG | 991 | O43861 | |
| KYLYAFSIVPMKLMD | 236 | Q69YN2 | |
| RNLMVYMYLPEAKES | 1276 | Q10570 | |
| MIQMLYYVKDIPATL | 141 | P50135 | |
| MLYLEDYLEMIEQLP | 1 | Q9NXR8 | |
| ELQDMLLLSMNPYDY | 341 | A7E2Y1 | |
| KNLMVYSLPTMEILY | 331 | P50748 | |
| YTLDDLYPMMNALKL | 736 | Q9UGL1 | |
| LYPMMNALKLRAESY | 741 | Q9UGL1 | |
| MLFDERKYPYHLMLQ | 1141 | Q7Z6Z7 | |
| PVDLYYLMDLSYSMK | 151 | P26010 | |
| GVMEYYLMDAASLLP | 151 | Q96CB9 | |
| YLVSAMLLEIPYMAA | 686 | Q99613 | |
| EIYKMTTDPMLAYLQ | 1751 | Q13315 | |
| YLLGPLYAALKMESM | 391 | Q13535 | |
| TLAKYLMELTMLDYD | 321 | P14635 | |
| MLLKMYSLGLQAYFV | 571 | Q13936 | |
| IASLYMPLYGMLLDN | 1201 | Q96BY6 | |
| MLLDNMPRIYLKDLY | 1211 | Q96BY6 | |
| LAKYLMELTLIDYDM | 286 | O95067 | |
| NPIYQMLELKLAMYI | 151 | O14772 | |
| MLELKLAMYIDFPLN | 156 | O14772 | |
| RYPILMKEYASALMA | 131 | Q8NGZ0 | |
| YMWKYISPLMLLSLL | 571 | Q9H2J7 | |
| FDIMKYLFMLLSDLP | 1756 | B5MCY1 | |
| MVLKLIAMDPYEYFQ | 791 | Q15858 | |
| MEYAMKSLSLLYPKS | 1 | Q96AQ7 | |
| LAEMYLPSYDSMLSK | 246 | Q8NA66 | |
| VLYLSKYVLNMMALL | 156 | Q8WWU5 | |
| NLEPERKYKMNMYGL | 1531 | P22105 | |
| LEMYGEMLAVSKLYP | 216 | P80108 | |
| PYRDMMLENYSLLLS | 61 | B1APH4 |